Opinion
Video
Author(s):
Joyce O’Shaughnessy, MD and Erin Cobain, MD, offer their reflections of genomic testing in breast cancer and its impact on clinical practice.
MRD Testing Requires Prospective Data to Assess Clinical Utility in Breast Cancer
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
Novel Prompt Shows Potential to Decrease Overtreatment in Older Patients With Early-Stage Breast Cancer
Revisit the OncLive On Air Episodes From February 2024
DESTINY-Breast03 and DESTINY-Breast06 Data Shape Metastatic Breast Cancer Treatment
Enhanced Clinical Education and Simplified Guidelines Needed to Address Germline Testing Gaps in Breast Cancer
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Dr Sabari on Barriers to Biomarker Testing in NSCLC
Dr Backhus on Surgical Eligibility in Borderline Resectable NSCLC